Publications

03-28 10:05
 
Clinic- and home-based contingency management plus parent training for adolescent cannabis use disorders
03-28 10:05
 
Positive psychotherapy for distressed cancer survivors: Posttraumatic growth facilitation reduces posttraumatic stress
03-28 10:05
 
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years
03-28 10:05
 
Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies
03-28 10:05
 
Dulaglutide 1.5 mg as an add-on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration
03-28 10:05
 
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial
03-28 10:05
 
Comparing group-based acceptance and commitment therapy (ACT) with enhanced usual care for adolescents with functional somatic syndromes: a study protocol for a randomised trial
03-28 10:05
 
NightBalance Sleep Position Treatment Device Versus Auto-Adjusting Positive Airway Pressure for Treatment of Positional Obstructive Sleep Apnea
03-28 10:05
 
Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
03-28 10:05
 
Hydrophilic interaction liquid chromatography-tandem mass spectrometric approach for simultaneous determination of safingol and D-erythro-sphinganine in human plasma
03-28 10:05
 
Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases
03-28 10:05
 
Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis
03-28 10:05
 
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
03-28 10:05
 
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed
03-28 10:05
 
The safety of vedolizumab for ulcerative colitis and Crohn's disease
03-28 10:05
 
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials
03-28 10:05
 
Urinary tract infections in the critical care unit: A brief review
03-28 10:05
 
Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3
03-28 10:05
 
Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release
03-28 10:05
 
Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms
03-28 10:05
 
Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults
03-28 10:05
 
A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
03-28 10:05
 
Slow release of nitric oxide from charged catheters and its effect on biofilm formation by Escherichia coli
03-28 10:05
 
Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study
03-28 10:05
 
Leucine supplementation of a low-protein mixed macronutrient beverage enhances myofibrillar protein synthesis in young men: a double-blind, randomized trial

Clinical Research News

Applying for a Paediatric investigation plan (PIP): review of the EMA guidelines
Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults

Kommende kliniske forsøg

Clinical Research Jobs

All jobs

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner